But to keep it relevant to NYR, they're in a good position given their 11mil, they've had delays but not burning through capital just waiting to use it. With only a 27 mil market cap if the have show safety and an efficacy signal in their phase 1 cholesterol trial, you'd have to think they will be an acquisition target. My mind still boggles at the cash vs current market cap. I'm still accumulating small amounts as I can.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.025(9.62%) |
Mkt cap ! $49.56M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 23.0¢ | $152.5K | 645.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 141100 | 2 |
View Market Depth
| Last trade - 15.59pm 19/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |